Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Unichem-Laboratories"

20 News Found

Unichem Laboratories receives 4 observations from USFDA for Pithampur API facility
Drug Approval | March 05, 2025

Unichem Laboratories receives 4 observations from USFDA for Pithampur API facility

The company will provide the necessary response on these observations to USFDA within stipulated 15 days


Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr
News | February 06, 2024

Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr

Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023


Unichem Laboratories sale its stake in Optimus Drugs
News | September 24, 2022

Unichem Laboratories sale its stake in Optimus Drugs

The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.


Unichem Laboratories receives ANDA approval for Carbamazepine Tablets
Drug Approval | August 24, 2022

Unichem Laboratories receives ANDA approval for Carbamazepine Tablets

Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia


Unichem Laboratories Q1 FY23 consolidated loss at Rs. 23.36 Cr
News | August 10, 2022

Unichem Laboratories Q1 FY23 consolidated loss at Rs. 23.36 Cr

The company has reported total income of Rs. 317.45 crores during the period ended June 30, 2022


Unichem Laboratories Q1FY22 consolidated loss at Rs. 11.48 Cr
News | August 01, 2021

Unichem Laboratories Q1FY22 consolidated loss at Rs. 11.48 Cr

The company posted net profit of Rs.2.43 crores for the period ended June 30, 2020.


Unichem Laboratories receives ANDA approval for Apremilast Tablets
News | February 20, 2021

Unichem Laboratories receives ANDA approval for Apremilast Tablets

Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .


Akums appoints Shantanu R Chobhe as Corporate Quality Assurance Head
People | September 05, 2024

Akums appoints Shantanu R Chobhe as Corporate Quality Assurance Head

Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry


Unichem receives ANDA approval for Doxazosin Tablets
Drug Approval | January 11, 2024

Unichem receives ANDA approval for Doxazosin Tablets

Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure


Unichem receives ANDA approval for Prasugrel Tablets
Drug Approval | August 31, 2023

Unichem receives ANDA approval for Prasugrel Tablets

Prasugrel tablets are indicated to reduce the rate of thrombotic CV events